From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...

Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression The INHALE-1 study is a 26-week, ...

The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing ...

Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

Read the winning essay from the Young Science Writer of the Year 2024 award ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Discover the truth behind Sugar Defender reviews, revealing how this blood sugar supplement helped control my levels and ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

Type 1 diabetes, once known as juvenile or insulin-dependent diabetes, is a chronic health condition. In people with this ...

Cipla received approval from India's Central Drugs Standard Control Organisation to distribute and market Afrezza inhalation ...

India has the 2nd highest burden of diabetes worldwideCDSCO decision follows existing approvals in the U.S.A. and BrazilMannKind expects to ship ...